Restriction of lipid motion in membranes triggered by beta-sheet aggregation of the anti-apoptotic BH4 domain

The FEBS Journal
Marc-Antoine SaniGerhard Gröbner

Abstract

The regulative BH4 domain of human Bcl-2 protein exerts its anti-apoptic activity via the mitochondrion. In the present study, we investigated the molecular interactions of this domain with negatively charged liposomes mimicking the outer mitochondrial membrane. To model the overproduction of Bcl-2 found in cancer processes, we studied the impact of elevated concentrations of its regulative BH4 segment on these mitochondrial membranes from the peptide and lipid perspective. Combined solid state (2)H-NMR and differential scanning calorimetry revealed the coexistence of small sized fluid and rigid membrane domains over a large temperature range, which is confirmed by (31)P-NMR at 30 degrees C. The latter are stabilized, in a cholesterol-like manner, by the presence of a BH4 peptide. In the same time scale, the reduction of the headgroup order is seen in the static (14)N and (31)P-NMR spectra when BH4 inserts into the bilayers. Indeed, attenuated total reflection spectroscopy indicated a dominant aggregated beta-sheet secondary structure of BH4 with a 42 degrees tilt relative to the membrane surface. These results are discussed in terms of membrane stabilization versus apoptotic mechanisms at the outer mitochondrial membrane locat...Continue Reading

References

Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·S Mabrey, J M Sturtevant
Aug 1, 1992·Biophysical Journal·R SmithB A Cornell
Mar 21, 1983·Biochimica Et Biophysica Acta·J H Davis
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M Sturtevant
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·B SchusterP Laggner
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·J M JürgensmeierJ C Reed
Aug 28, 1998·Science·D R Green, J C Reed
Sep 29, 1998·Methods in Enzymology·J T Mason
Jul 7, 1999·Biochimica Et Biophysica Acta·E GoormaghtighJ M Ruysschaert
Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·S ShimizuY Tsujimoto
Mar 31, 2000·Experimental Cell Research·M Loeffler, G Kroemer
May 10, 2000·Nature Medicine·G Kroemer, J C Reed
Jul 6, 2000·Journal of the National Cancer Institute·P CostantiniG Kroemer
Oct 26, 2000·Nature·M O Hengartner
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A M PetrosS W Fesik
Mar 30, 2001·The Journal of Biological Chemistry·V MikhailovP Saikumar
Apr 20, 2001·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·V P Ivanova, T Heimburg
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·N Zamzami, G Kroemer
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Nov 25, 2003·Oncogene·Rie SugiokaYoshihide Tsujimoto
Aug 3, 2004·Nature Reviews. Cancer·Hitoshi Okada, Tak W Mak
Sep 17, 2004·Biochemical and Biophysical Research Communications·Dagmar KleinRicardo L Pastori

❮ Previous
Next ❯

Citations

Jun 28, 2011·Molecular Biology and Evolution·Yannis GuilleminAbdel Aouacheria
Aug 24, 2013·Nature·Pierrick UzureauEtienne Pays
Sep 22, 2012·Biophysical Journal·Jacques P F DouxJ Antoinette Killian
Oct 27, 2011·Progress in Nuclear Magnetic Resonance Spectroscopy·Luke A O'Dell

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Biochemical and Biophysical Research Communications
Youli WangZiwei Huang
Journal of Peptide Science : an Official Publication of the European Peptide Society
Lucie KhemtémourianErick J Dufourc
Journal of Peptide Science : an Official Publication of the European Peptide Society
Marc-Antoine SaniErick J Dufourc
© 2021 Meta ULC. All rights reserved